{"SPADE_N_15579": {"Sequence Information": {"Peptide Name": "Majusculamide C", "Sequence": "GXGXXXAX", "Sequence Length": 8, "Biological Activity": ["Anticancer"], "Binding Target": "1. Mitochondrial membrane", "Source": "1. Lyngbya majuscula\n2. Ptilocaulis trachys\n3. Dolabella auricularia", "Gene": "", "PDB ID": "", "UniProt Entry": [], "Literature": [{"Title": "Antineoplastic agents. 536. New sources of naturally occurring cancer cell growth inhibitors from marine organisms, terrestrial plants, and microorganisms", "Pubmed ID": "18327911", "Reference": "J Nat Prod. 2008;71:438-444", "Author": "Pettit GR, Hogan F, Xu JP, Tan R, Nogawa T, Cichacz Z, Pettit RK, Du J, Ye QH, Cragg GM, Herald CL, Hoard MS, Goswami A, Searcy J, Tackett L, Doubek DL, Williams L, Hooper JN, Schmidt JM, Chapuis JC, Tackett DN, Craciunescu F", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/18327911"}], "SPADE ID": "SPADE_N_15579", "Similar Sequences": [{"SPADE_ID": "SPADE_N_00019", "Similarity": 1.0, "Sequence": "GTPLALLGGAATGVIGYISNQTCPTTACTRAC"}, {"SPADE_ID": "SPADE_N_00063", "Similarity": 1.0, "Sequence": "KYYGNGVSCNKKGCSVDWGKAIGIIGNNSAANLATGGAAGWSK"}, {"SPADE_ID": "SPADE_N_00064", "Similarity": 1.0, "Sequence": "KYYGNGVSCNKKGCSVDWGKAIGIIGNNSAANLATGGAAGWKS"}], "Hemolytic Activity": "", "Target Organism": "Human epithelial carcinoma OVCAR-3(IC50=0.51µg/ml),Human renal carcinoma A498(IC50=0.058µg/ml),Human lung carcinoma NCI-H460(IC50=0.0032µg/ml),Human colon adenocarcinoma KM20L2(IC50=0.0013µg/ml),Human skin melanoma SK-MEL-5(IC50=0.0068µg/ml),Human glioblastoma SF-295(IC50=0.13µg/ml)"}}}